How to buy TransMedics Group stock (TMDX)

TransMedics Group is a medical devices business based in the US. TransMedics Group shares (TMDX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $60.88 – a decrease of 9.62% over the previous week. TransMedics Group employs 584 staff and has a trailing 12-month revenue of around $401.1 million.

Our top picks for where to buy TransMedics Group stock

Buy TransMedics Group stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

TransMedics Group stock price (NASDAQ: TMDX)

Use our graph to track the performance of TMDX stocks over time.

TransMedics Group shares at a glance

• Key figures

Information last updated 2024-12-11.

Latest market close	$60.88
52-week range	$65.26 - $177.37
50-day moving average more info button	$101.50
200-day moving average more info button	$121.59
Wall St. target price	$116.75
PE ratio more info button	72.4301
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.93

Is it a good time to buy TransMedics Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TransMedics Group price performance over time

Historical closes compared with the close of $65.705 from 2024-12-17

1 week (2024-12-12)	-0.01%
1 month (2024-11-19)	-20.76%
3 months (2024-09-19)	-60.41%
6 months (2024-06-18)	-54.98%

1 year (2023-12-19)	-16.01%
2 years (2022-12-19)	18.54%
3 years (2021-12-17)	217.88%
5 years (2019-12-19)	255.74%

Is TransMedics Group stock undervalued or overvalued?

Valuing TransMedics Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TransMedics Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

TransMedics Group's P/E ratio

TransMedics Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, TransMedics Group shares trade at around 72x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

TransMedics Group's EBITDA

TransMedics Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $51.1 million.

The EBITDA is a measure of a TransMedics Group's overall financial performance and is widely used to measure a its profitability.

TransMedics Group financials

Revenue TTM	$401.1 million
Operating margin TTM	3.61%
Gross profit TTM	$65.3 million
Return on assets TTM	2.84%
Return on equity TTM	19.41%
Profit margin	8.14%
Book value	$6.26
Market Capitalization more info button	$2.3 billion

TTM: trailing 12 months

TransMedics Group share dividends

We're not expecting TransMedics Group to pay a dividend over the next 12 months.

TransMedics Group share price volatility

Over the last 12 months, TransMedics Group's shares have ranged in value from as little as $65.26 up to $177.37. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TransMedics Group's is 2.071. This would suggest that TransMedics Group's shares are significantly more volatile than the average for this exchange and represent a higher risk.

TransMedics Group overview

TransMedics Group, Inc. , a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. .

Frequently asked questions

What percentage of TransMedics Group is owned by insiders or institutions?
Currently 3.177% of TransMedics Group shares are held by insiders and 112.999% by institutions. How many people work for TransMedics Group?
Latest data suggests 584 work at TransMedics Group. When does the fiscal year end for TransMedics Group?
TransMedics Group's fiscal year ends in December. Where is TransMedics Group based?
TransMedics Group's address is: 200 Minuteman Road, Andover, MA, United States, 01810 What is TransMedics Group's ISIN number?
TransMedics Group's international securities identification number is: US89377M1099 What is TransMedics Group's CUSIP number?
TransMedics Group's Committee on Uniform Securities Identification Procedures number is: 89377M109